Otolaryngology (“ENT”), allergy, and asthma (“ENTA&A”) related medical practices have been enjoying a robust period of investor interest as private-equity backed physician-practice management (“PPM”) companies and health systems have sought to align with providers in this sector. With opportunities for multiple ancillary offerings such as audiology and hearing aid sales, to the ability for ENT physicians to perform outpatient surgeries in an ambulatory surgery center (“ASC”) setting, there will likely be continued investor interest in this sector for years to come. This article discusses the key drivers to transaction activity in the ENTA&A sector, provides insight into the current transaction environment, and outlines the value proposition that different buyers typically bring to a potential transaction.
Read the full article: 2024 Industry Outlook: ENT, Allergy, and Asthma Practices //
Source: https://healthcareappraisers.com/2024-industry-outlook-ent-allergy-and-asthma-practices